The Europe Bioabsorbable Stents Market is expected to witness market growth of 6.6% CAGR during the forecast period (2021-2027).
Stents are fixed in the artery with an aim to eliminate the blockades in the heart during the surgical procedure known as a percutaneous coronary intervention. Stents assists in opening the arteries and decreases the possibility of heart attacks. Conventionally, stents are developed from metal mesh and stay in the body permanently until they are taken out with the help of surgical intervention. However, these days, bioabsorbable stents are created with materials that easily get dissolved or absorbed in the body. There is no permanent implantation of a bioabsorbable stent. It gets slowly resorbed and harmlessly cleared from the body.
The European region is witnessing a rise in aging population, specifically those who are more vulnerable to heart-related diseases that require surgeries related to stents. This is a major driver for the demand & growth of bioabsorbable stents in the region. existence of many players in the European region who are constantly coming up with novel devices in the medical domain of coronary stents, is expected to speed up the growth of the European bioabsorbable stents market.
However, people are getting more aware of the side effects that arise post-surgery of stents, which could hinder the further development of the market. On the other hand, physicians working in the regional market are constantly demanding better tools to treat highly complex cases, which involve multiple or completely blocked arteries and complications like diabetes. Responding to these demands, many players operating in the regional market are coming up with new products with the goal of assisting many people with coronary artery disease to regain their health and return to their daily lives as soon as possible.
The Germany market dominated the Europe Peripheral Artery Disease Market by Country in 2020, thereby, achieving a market value of $8.6 Million by 2027. The UK market is exhibiting a CAGR of 6.2% during (2021-2027). Additionally, The France market is anticipated to witness a CAGR of 8.5% during (2021-2027).
Based on Biomaterial, the market is segmented into Polymeric and Metallic. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End User, the market is segmented into Hospital and Cardiac Center. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Terumo Corporation, Arterius Ltd., Elixir Medical Corporation, Amaranth Medical, Inc., and REVA Medical, LLC.
Scope of the Study
Market Segments covered in the Report:
By Biomaterial
By Application
By End User
By Country
Companies Profiled
Unique Offerings from the Publisher
Stents are fixed in the artery with an aim to eliminate the blockades in the heart during the surgical procedure known as a percutaneous coronary intervention. Stents assists in opening the arteries and decreases the possibility of heart attacks. Conventionally, stents are developed from metal mesh and stay in the body permanently until they are taken out with the help of surgical intervention. However, these days, bioabsorbable stents are created with materials that easily get dissolved or absorbed in the body. There is no permanent implantation of a bioabsorbable stent. It gets slowly resorbed and harmlessly cleared from the body.
The European region is witnessing a rise in aging population, specifically those who are more vulnerable to heart-related diseases that require surgeries related to stents. This is a major driver for the demand & growth of bioabsorbable stents in the region. existence of many players in the European region who are constantly coming up with novel devices in the medical domain of coronary stents, is expected to speed up the growth of the European bioabsorbable stents market.
However, people are getting more aware of the side effects that arise post-surgery of stents, which could hinder the further development of the market. On the other hand, physicians working in the regional market are constantly demanding better tools to treat highly complex cases, which involve multiple or completely blocked arteries and complications like diabetes. Responding to these demands, many players operating in the regional market are coming up with new products with the goal of assisting many people with coronary artery disease to regain their health and return to their daily lives as soon as possible.
The Germany market dominated the Europe Peripheral Artery Disease Market by Country in 2020, thereby, achieving a market value of $8.6 Million by 2027. The UK market is exhibiting a CAGR of 6.2% during (2021-2027). Additionally, The France market is anticipated to witness a CAGR of 8.5% during (2021-2027).
Based on Biomaterial, the market is segmented into Polymeric and Metallic. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End User, the market is segmented into Hospital and Cardiac Center. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Terumo Corporation, Arterius Ltd., Elixir Medical Corporation, Amaranth Medical, Inc., and REVA Medical, LLC.
Scope of the Study
Market Segments covered in the Report:
By Biomaterial
- Polymeric
- Metallic
By Application
- Coronary Artery Disease
- Peripheral Artery Disease
By End User
- Hospital
- Cardiac Center
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Abbott Laboratories
- B. Braun Melsungen AG
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Terumo Corporation
- Arterius Ltd.
- Elixir Medical Corporation
- Amaranth Medical, Inc.
- REVA Medical, LLC
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Bioabsorbable Stents Market, by Biomaterial
1.4.2 Europe Bioabsorbable Stents Market, by Application
1.4.3 Europe Bioabsorbable Stents Market, by End User
1.4.4 Europe Bioabsorbable Stents Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Bioabsorbable Stents Market by Biomaterial
3.1 Europe Polymeric Market by Country
3.2 Europe Metallic Market by Country
Chapter 4. Europe Bioabsorbable Stents Market by Application
4.1 Europe Coronary Artery Disease Market by Country
4.2 Europe Peripheral Artery Disease Market by Country
Chapter 5. Europe Bioabsorbable Stents Market by End User
5.1 Europe Hospital Market by Country
5.2 Europe Cardiac Center Market by Country
Chapter 6. Europe Bioabsorbable Stents Market by Country
6.1 Germany Bioabsorbable Stents Market
6.1.1 Germany Bioabsorbable Stents Market by Biomaterial
6.1.2 Germany Bioabsorbable Stents Market by Application
6.1.3 Germany Bioabsorbable Stents Market by End User
6.2 UK Bioabsorbable Stents Market
6.2.1 UK Bioabsorbable Stents Market by Biomaterial
6.2.2 UK Bioabsorbable Stents Market by Application
6.2.3 UK Bioabsorbable Stents Market by End User
6.3 France Bioabsorbable Stents Market
6.3.1 France Bioabsorbable Stents Market by Biomaterial
6.3.2 France Bioabsorbable Stents Market by Application
6.3.3 France Bioabsorbable Stents Market by End User
6.4 Russia Bioabsorbable Stents Market
6.4.1 Russia Bioabsorbable Stents Market by Biomaterial
6.4.2 Russia Bioabsorbable Stents Market by Application
6.4.3 Russia Bioabsorbable Stents Market by End User
6.5 Spain Bioabsorbable Stents Market
6.5.1 Spain Bioabsorbable Stents Market by Biomaterial
6.5.2 Spain Bioabsorbable Stents Market by Application
6.5.3 Spain Bioabsorbable Stents Market by End User
6.6 Italy Bioabsorbable Stents Market
6.6.1 Italy Bioabsorbable Stents Market by Biomaterial
6.6.2 Italy Bioabsorbable Stents Market by Application
6.6.3 Italy Bioabsorbable Stents Market by End User
6.7 Rest of Europe Bioabsorbable Stents Market
6.7.1 Rest of Europe Bioabsorbable Stents Market by Biomaterial
6.7.2 Rest of Europe Bioabsorbable Stents Market by Application
6.7.3 Rest of Europe Bioabsorbable Stents Market by End User
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals & Trials:
7.1.5.2 Acquisition and Mergers:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 BIOTRONIK SE & Co. KG
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Approvals & Trials:
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 MicroPort Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Terumo Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.7 Arterius Ltd.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 Elixir Medical Corporation
7.8.1 Company Overview
7.9 Amaranth Medical, Inc.
7.9.1 Company Overview
7.10. REVA Medical, Inc.
7.10.1 Company OverviewList of Tables
Table 1 Europe Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 2 Europe Bioabsorbable Stents Market, 2021-2027, USD Million
Table 3 Europe Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 4 Europe Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 5 Europe Polymeric Market by Country, 2017 - 2020, USD Million
Table 6 Europe Polymeric Market by Country, 2021-2027, USD Million
Table 7 Europe Metallic Market by Country, 2017 - 2020, USD Million
Table 8 Europe Metallic Market by Country, 2021-2027, USD Million
Table 9 Europe Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 10 Europe Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 11 Europe Coronary Artery Disease Market by Country, 2017 - 2020, USD Million
Table 12 Europe Coronary Artery Disease Market by Country, 2021-2027, USD Million
Table 13 Europe Peripheral Artery Disease Market by Country, 2017 - 2020, USD Million
Table 14 Europe Peripheral Artery Disease Market by Country, 2021-2027, USD Million
Table 15 Europe Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 16 Europe Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 17 Europe Hospital Market by Country, 2017 - 2020, USD Million
Table 18 Europe Hospital Market by Country, 2021-2027, USD Million
Table 19 Europe Cardiac Center Market by Country, 2017 - 2020, USD Million
Table 20 Europe Cardiac Center Market by Country, 2021-2027, USD Million
Table 21 Europe Bioabsorbable Stents Market by Country, 2017 - 2020, USD Million
Table 22 Europe Bioabsorbable Stents Market by Country, 2021-2027, USD Million
Table 23 Germany Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 24 Germany Bioabsorbable Stents Market, 2021-2027, USD Million
Table 25 Germany Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 26 Germany Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 27 Germany Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 28 Germany Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 29 Germany Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 30 Germany Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 31 UK Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 32 UK Bioabsorbable Stents Market, 2021-2027, USD Million
Table 33 UK Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 34 UK Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 35 UK Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 36 UK Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 37 UK Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 38 UK Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 39 France Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 40 France Bioabsorbable Stents Market, 2021-2027, USD Million
Table 41 France Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 42 France Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 43 France Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 44 France Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 45 France Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 46 France Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 47 Russia Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 48 Russia Bioabsorbable Stents Market, 2021-2027, USD Million
Table 49 Russia Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 50 Russia Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 51 Russia Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 52 Russia Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 53 Russia Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 54 Russia Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 55 Spain Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 56 Spain Bioabsorbable Stents Market, 2021-2027, USD Million
Table 57 Spain Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 58 Spain Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 59 Spain Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 60 Spain Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 61 Spain Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 62 Spain Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 63 Italy Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 64 Italy Bioabsorbable Stents Market, 2021-2027, USD Million
Table 65 Italy Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 66 Italy Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 67 Italy Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 68 Italy Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 69 Italy Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 70 Italy Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 71 Rest of Europe Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 72 Rest of Europe Bioabsorbable Stents Market, 2021-2027, USD Million
Table 73 Rest of Europe Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 74 Rest of Europe Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 75 Rest of Europe Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 76 Rest of Europe Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 77 Rest of Europe Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 78 Rest of Europe Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 79 Key Information - Abbott Laboratories
Table 80 key Information - B. Braun Melsungen AG
Table 81 Key Information - BIOTRONIK SE & Co. KG
Table 82 key Information - Boston Scientific Corporation
Table 83 key Information - MicroPort Scientific Corporation
Table 84 Key Information - Terumo Corporation
Table 85 key information - Arterius Ltd.
Table 86 key information - Elixir Medical Corporation
Table 87 key information - Amaranth Medical, Inc.
Table 88 key information - REVA Medical, LLC
List of Figures
Fig 1 Methodology for the research
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Terumo Corporation
- Arterius Ltd.
- Elixir Medical Corporation
- Amaranth Medical, Inc.
- REVA Medical, LLC
Methodology
LOADING...
